Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENESYS: Nebivolol vs Metoprolol in Hypertension
NCT00942487Phase 3Completed
- Sponsor
- Berlin-Chemie AG
- Start
- Apr 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nebivolol in primary hypertension (2 arms), sponsored by Berlin-Chemie AG. Primary endpoints: Longitudinal myocardial velocities at rest at 6 months, Systolic functional reserve at 6 months and 1 more. Started Apr 2005; status: completed.
02
Drugs
nebivolol
03
Conditions
primary hypertension
Beyond the preview
Go deeper on NCT00942487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00942487.